Ipsen

Title:Estágio - MarketingCompany:Beaufour Ipsen Farmaceutica LtdaAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development

Title:Estágio - MarketingCompany:Beaufour Ipsen Farmaceutica LtdaAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development

Title:Medical Science Liaison Oncology (CDMX GDL o MTY)Company:Ipsen Mexico S de RL de CVAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 1

Title:Medical Science Liaison Oncology (CDMX GDL o MTY)Company:Ipsen Mexico S de RL de CVAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 1

Title:Regional Product Manager - GuangzhouCompany:Ipsen (Tianjin) Pharmaceutical Trade Co. LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nea

Title:Regional Product Manager - GuangzhouCompany:Ipsen (Tianjin) Pharmaceutical Trade Co. LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nea

Title:Senior Sales Specialist (Oncology & Neuroscience) South TaiwanCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nea

Title:Senior Sales Specialist (Oncology & Neuroscience) South TaiwanCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nea

Title:Senior GCP/PV Quality Auditor (Remote)Company:Ipsen Biopharm LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of develop

Title:Senior GCP/PV Quality Auditor (Remote)Company:Ipsen Biopharm LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of develop

Title:Business Unit Head OncologyCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experi

Title:Business Unit Head OncologyCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experi

Title:Director BiostatisticsCompany:Ipsen Innovation (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experie

Title:Director BiostatisticsCompany:Ipsen Innovation (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experie

Title:Lead Statistical Programming Architect Macro Automation & AICompany:Ipsen Innovation (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by

Title:Lead Statistical Programming Architect Macro Automation & AICompany:Ipsen Innovation (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by

Title:HR InternCompany:Ipsen Biopharm LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global h

Title:HR InternCompany:Ipsen Biopharm LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global h

Title:Business Unit HeadCompany:Ipsen LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global h

Title:Business Unit HeadCompany:Ipsen LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global h

Title:Manager Communications & Patient Advocacy - Oncology DACH (w/m/d)Company:Ipsen Pharma GmbHAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by n

Title:Manager Communications & Patient Advocacy - Oncology DACH (w/m/d)Company:Ipsen Pharma GmbHAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by n

Title:PV Partnering Senior Manager - 8 months FTC / CDD 8 moisCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 10

Title:PV Partnering Senior Manager - 8 months FTC / CDD 8 moisCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 10

Title:Senior Manager Biomarker OperationsCompany:Ipsen Innovation (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of develo

Title:Senior Manager Biomarker OperationsCompany:Ipsen Innovation (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of develo

Title:Head of Global Field Medical Strategy (MSLs)Company:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of d

Title:Head of Global Field Medical Strategy (MSLs)Company:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of d

Title:Senior Controller R&D Finance - Oncology Assets - CDD à partir de mi-avril 2026 - H/FCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuros

Title:Senior Controller R&D Finance - Oncology Assets - CDD à partir de mi-avril 2026 - H/FCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuros

Title:Head of Evidence Generation - International RegionCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 year

Title:Head of Evidence Generation - International RegionCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 year

Title:Regional Product Manager - BeijingCompany:Ipsen (Shanghai) Trade Co. LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of

Title:Regional Product Manager - BeijingCompany:Ipsen (Shanghai) Trade Co. LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of

Title:Consultor Técnico de Vendas - Oncologia - Porto Alegre/RSCompany:Beaufour Ipsen Farmaceutica LtdaAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Support

Title:Consultor Técnico de Vendas - Oncologia - Porto Alegre/RSCompany:Beaufour Ipsen Farmaceutica LtdaAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Support

Title:Global Medical Writing ManagerCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development exp

Title:Global Medical Writing ManagerCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development exp

Title:OneOps Service and Performance LeadCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of developmen

Title:OneOps Service and Performance LeadCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of developmen